TGF ‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential
Journal of Neuroscience Research · 2024-01 · 102 (1)
DOI: 10.1002/jnr.25255 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, online erschienen am 10.10.2023. Verfasst von Chun-Wei Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a highly disabling central nervous system injury with a complex pathological process, resulting in severe sensory and motor dysfunction. The current treatment modalities only alleviate its symptoms and cannot effectively intervene or treat its pathological process. Many studies have reported that the transforming growth factor (TGF)‐β signaling pathway plays an important role in neuronal differentiation, growth, survival, and axonal regeneration after central nervous system injury. Furthermore, the TGF‐β signaling pathway has a vital regulatory role in SCI pathophysiology and neural regeneration. Following SCI, regulation of the TGF‐β signaling pathway can suppress inflammation, reduce apoptosis, prevent glial scar formation, and promote neural regeneration. Due to its role in SCI, the TGF‐β signaling pathway could be a potential therapeutic target. This article reported the pathophysiology of SCI, the characteristics of the TGF‐β signaling pathway, the role of the TGF‐β signaling pathway in SCI, and the latest evidence for targeting the TGF‐β signaling pathway for treating SCI. In addition, the limitations and difficulties in TGF‐β signaling pathway research in SCI are discussed, and solutions are provided to address these potential challenges. We hope this will provide a reference for the TGF‐β signaling pathway and SCI research, offering a theoretical basis for targeted therapy of SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou, China.
- The Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, C. W., Wang, Z. Q., Ran, R., Liao, H. Y., Lyu, J. Y., Ren, Y., Lei, Z. Y., & Zhang, H. H. (2024). TGF ‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential. Journal of Neuroscience Research, 102(1). https://doi.org/10.1002/jnr.25255
Vancouver
Ma CW, Wang ZQ, Ran R, Liao HY, Lyu JY, Ren Y, et al. TGF ‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential. Journal of Neuroscience Research. 2024;102(1). doi:10.1002/jnr.25255
BibTeX
@article{Ma2024,
author = {Ma, Chun-Wei and Wang, Zhi-Qiang and Ran, Rui and Liao, Hai-Yang and Lyu, Jia-Yang and Ren, Yi and Lei, Ze-Yuan and Zhang, Hai-Hong},
title = {TGF ‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential},
journal = {Journal of Neuroscience Research},
year = {2024},
volume = {102},
number = {1},
doi = {10.1002/jnr.25255}
}
EUVIMED